Category: COVID-19
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
-
Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis
June 26, 2022DCS 1401: Venous thromboembolism (VTE) prophylaxis
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
-
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
September 17, 2021The role of Heparin in the management of thrombosis in COVID-19
-
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19
July 31, 2021thromboprophylaxis in COVID-19
-
Cardio-Watch Podcast: Episode one; COVID-19 and the heart
May 15, 2021The first episode of Cardio-Watch podcast
-
Impact: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomized, open-label trial
January 20, 2021Continue vs Stop of RAS inhibitors in patients with COVID-19
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
-
Case Discussion (7)
May 29, 2020Approach to chest pain in a patient with a history of CCS in the era of COVID-19 pandemic
-
Save the date: Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 13, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 12, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 10, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
Save the date: COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 3, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
The evolving pandemic of COVID-19 and invasive cardiology consideration
April 6, 2020Brief description of COVID-19 effect on approaching invasive strategies in patients with CVD
-
Save the Date: The evolving pandemic of COVID-19 and invasive cardiology consideration
April 6, 2020Brief description of COVID-19 effect on approaching invasive strategies in patients with CVD
-
Save the date: COVID and Cardiometabolic Challenges
April 3, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
-
At a glance: ACEI and ARB in COVID-19 Era
March 19, 2020The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Save the date: COVID-19 Sharing Facts, Not the Fear
March 3, 2020Quick review on COVID-19 from an ID Perspective
-